AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors
https://www.zacks.com/stock/news/2254098/abbvie-abbv-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2254098
Apr 11, 2024 - The latest trading day saw AbbVie (ABBV) settling at $167.52, representing a -0.89% change from its previous close.
0
Are You Looking for a High-Growth Dividend Stock?
https://www.zacks.com/stock/news/2253493/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2253493
Apr 10, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
0
Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML
https://www.zacks.com/stock/news/2253351/syros-syrs-up-on-fda-fast-track-tag-for-tamibarotene-in-aml?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253351
Apr 10, 2024 - The FDA bestows a Fast Track Designation to Syros' (SYRS) pipeline candidate, tamibarotene, in combination with venetoclax and azacitidine to treat newly diagnosed acute myeloid leukemia. Stock rises.
0
Top Stock Reports for AbbVie, Salesforce & General Electric
https://www.zacks.com/commentary/2252707/top-stock-reports-for-abbvie-salesforce-general-electric?cid=CS-ZC-FT-research_daily-2252707
Apr 09, 2024 - Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Salesforce, Inc. (CRM) and General Electric Company (GE).
0
Pages: 1
Page 1